A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
29 Sep 2026 · 04:46 CST Terminal Access 终端入口 →
000504.SZ深圳证券交易所 · 主板 Main

NanHua Bio-medicine 南华生物

Healthcare Services 医疗服务
¥12.36−¥1.37 · −9.98%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥13.05
High 最高
¥13.49
Low 最低
¥12.36
Prev Close 昨收
¥13.73
Volume 成交量
1,403.3万股
Turnover 成交额
¥1.80亿
Mkt Cap 总市值
¥41亿
P/E 市盈率
106.5×
Recent Activity 近期动态All Filings 全部公告 →

5 significant filings since 1 Jun 2026: 2 on regulatory inquiry, 1 on earnings pre-announcement and 1 on delisting warning lifted, and 1 other kind. The latest, on 10 Jul 2026: 2026-037 南华生物2026年半年度业绩预告的公告. On 10 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to rise by 220.54% to 277.94% from the same period a year earlier.
自 1 Jun 2026 起有 5 份重大公告:regulatory inquiry 2 份、earnings pre-announcement 1 份、delisting warning lifted 1 份,另有 1 类。最新一份(10 Jul 2026):2026-037 南华生物2026年半年度业绩预告的公告。10 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期上升 220.54% 至 277.94%。

Price History 价格走势

5 sessions 个交易日, 21 Sep to 28 Sep 2026 · Live one-minute prices 实时分钟价格 · High 最高 ¥14.04 · Low 最低 ¥11.01 · −9.98% on the previous close of ¥13.73 较昨收
11.5012.0012.5013.0013.5014.00
Volume 成交量
10.2万
21 Sep22 Sep23 Sep24 Sep28 Sep

Key Metrics 核心指标

Reporting Period 报告期 · 30 Jun 2026 中报
Revenue 营业收入
¥2.96亿
YoY 同比 +473.56%
Net Profit 净利润
¥599.3万
YoY 同比 +271.99%
10.01%
0.29%
2.23%
Not annualised
59.28%
−0.02×